Log in or Sign up for Free to view tailored content for your specialty!
Intervention News
FDA approves 160 cm endovascular navigation wire with 3D imaging guidance
Philips announced the FDA approved the 160 cm version of its endovascular navigation wire that uses fiber optic technology.
Premarket research not conducted for many CV devices subject to class I recall
Many recently recalled cardiovascular devices did not undergo premarket testing prior to FDA approval, and postmarket studies of the devices were slow and infrequent, researchers reported.
Shared decision-making key for invasive vs. conservative MI strategy in elderly: SENIOR-RITA
For older adults with non-STEMI, routine coronary intervention was safe but did not lower risk for death from CV causes or nonfatal MI compared with medical therapy alone, according to new data from the SENIOR-RITA trial.
Log in or Sign up for Free to view tailored content for your specialty!
Fasting not necessary for cardiac catheterization procedures with conscious sedation
Not fasting before cardiac catheterization procedures with conscious sedation was noninferior and likely superior to fasting for safety, and improved patient satisfaction, researchers reported at the European Society of Cardiology Congress.
TAVR superior to surgery at 1 year for women with severe aortic stenosis: RHEIA
Women with symptomatic severe aortic stenosis had better outcomes at 1 year after transcatheter aortic valve replacement with a balloon-expandable valve compared with women who underwent surgery, according to new data from the RHEIA trial.
Coronary implant noninferior to DES at 1 year, tied to event reduction after 6 months
The bioadaptor implant adaptable to vessel physiology was noninferior to a drug-eluting stent for target lesion failure at 1 year, and reduced event rates vs. the DES after 6 months, researchers reported.
Temporary interruption of anticoagulant use during TAVR appears safe
Halting oral anticoagulation during transcatheter aortic valve replacement was not noninferior to anticoagulant continuation, but conferred lower bleeding risk and had no impact on thromboembolic risk, a speaker reported.
Patients with CAD undergoing TAVR may also benefit from angioplasty
In patients with coronary artery disease and severe aortic stenosis undergoing transcatheter aortic valve replacement, those who also had PCI had better outcomes than those who had their CAD managed conservatively, researchers reported.
TEER noninferior to surgery in patients with heart failure, mitral regurgitation
In patients with HF and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral valve surgery for efficacy and was linked with fewer safety endpoint events, according to data from the MATTERHORN trial.
MitraClip improves outcomes in patients with less severe mitral regurgitation, heart failure
Transcatheter mitral valve repair in addition to medical therapy led to a lower rate of CV events and hospitalizations and better health status compared with medical therapy alone for patients with HF and moderate to severe mitral regurgitation.
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read
-
Headline News
‘The mind is medicine’: How virtual reality can cool bothersome hot flashes
September 18, 20244 min read -
Headline News
CDC: Close contact of Missouri bird flu case had symptoms but was not tested
September 17, 20242 min read -
Headline News
Metformin use may lower risk for long COVID in adults with type 2 diabetes
September 18, 20243 min read